Asymptomatic tiny subcutaneous eruptions in a patient with sarcoid neuropathy: the effectiveness of fluorine-18 fluorodeoxyglucose positron emission tomography for targeting safe biopsy sites.
作者信息
Kobayashi Makoto
机构信息
Department of Neurology, Asahi General Hospital, Asahi, Chiba, Japan.
出版信息
Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(4):325-328. doi: 10.36141/svdld.v36i4.8436. Epub 2019 May 1.
Abstract
摘要
相似文献
1
Asymptomatic tiny subcutaneous eruptions in a patient with sarcoid neuropathy: the effectiveness of fluorine-18 fluorodeoxyglucose positron emission tomography for targeting safe biopsy sites.
Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(4):325-328. doi: 10.36141/svdld.v36i4.8436. Epub 2019 May 1.
2
Reticuloendothelial system involvement in untreated sarcoidosis patients as assessed by 18F-FDG PET scanning.
Sarcoidosis Vasc Diffuse Lung Dis. 2016 Dec 23;33(4):423-425.
3
Neurosarcoidosis and infliximab therapy monitored by 18FDG PET/CT.
QJM. 2019 Sep 1;112(9):695-697. doi: 10.1093/qjmed/hcz148.
4
Whole-Body 18F-FDG PET-CT in the Diagnosis of Neurosarcoidosis.
Mayo Clin Proc. 2020 May;95(5):1082-1084. doi: 10.1016/j.mayocp.2020.01.032.
5
Prognostic Value of F-FDG PET Using Texture Analysis in Cardiac Sarcoidosis.
JACC Cardiovasc Imaging. 2020 Apr;13(4):1096-1097. doi: 10.1016/j.jcmg.2019.11.021. Epub 2020 Jan 15.
6
Usefulness of 18F-FDG-PET/CT imaging in a patient with neurosarcoidosis.
Med Clin (Barc). 2018 Dec 14;151(11):464-465. doi: 10.1016/j.medcli.2018.02.024. Epub 2018 Apr 21.
7
FDG PET findings leading to diagnosis of neurosarcoidosis.
Clin Neurol Neurosurg. 2013 Jan;115(1):85-8. doi: 10.1016/j.clineuro.2012.03.042. Epub 2012 Apr 13.
8
Neurosarcoidosis on FET and FDG PET/CT.
Clin Nucl Med. 2017 Mar;42(3):197-199. doi: 10.1097/RLU.0000000000001516.
9
Blood Sugar and Ketosis in PET-FDG Sarcoid Imaging: Finding the Sweet Spot.
Circ Cardiovasc Imaging. 2024 Aug;17(8):e017251. doi: 10.1161/CIRCIMAGING.124.017251. Epub 2024 Jul 31.
10
Repeatability and Optimization of FDG Positron Emission Tomography for Evaluation of Cardiac Sarcoidosis.
JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 1):1284-1287. doi: 10.1016/j.jcmg.2019.01.011. Epub 2019 Mar 4.
本文引用的文献
1
A case of relapsing isolated neurosarcoidosis in an 18-year-old male patient successfully treated by corticosteroids.
Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(1):79-85. doi: 10.36141/svdld.v36i1.7168. Epub 2019 May 1.
2
Neurosarcoidosis in a public safety net hospital: a study of 82 cases.
Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(1):25-32. doi: 10.36141/svdld.v36i1.7106. Epub 2019 May 1.
3
Scar sarcoidosis: A rare entity found by 18F-FDG-PET/CT.
Radiol Case Rep. 2018 Sep 15;13(6):1216-1219. doi: 10.1016/j.radcr.2018.07.023. eCollection 2018 Dec.
4
Nuclear Imaging in Sarcoidosis.
Semin Nucl Med. 2018 May;48(3):246-260. doi: 10.1053/j.semnuclmed.2018.02.005. Epub 2018 Mar 9.
5
Cutaneous Manifestation of Sarcoidosis in Lower-Back Tattoo With Increased Uptake of 18F-FDG.
Clin Nucl Med. 2018 Jun;43(6):454-455. doi: 10.1097/RLU.0000000000002061.
6
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18;31(1):19-27.
7
FDG PET imaging in sarcoidosis.
Semin Nucl Med. 2013 Nov;43(6):404-11. doi: 10.1053/j.semnuclmed.2013.06.007.
8
Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease.
J Am Acad Dermatol. 2012 May;66(5):699.e1-18; quiz 717-8. doi: 10.1016/j.jaad.2011.11.965.
9
Fluorodeoxyglucose PET/CT in subcutaneous sarcoidosis mimicking cutaneous lymphoma.
Eur J Nucl Med Mol Imaging. 2012 May;39(5):919-20. doi: 10.1007/s00259-012-2068-1.
10
Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review.
Sarcoidosis Vasc Diffuse Lung Dis. 2011 Oct;28(2):87-94.
Zotero 插件